Welcome to our dedicated page for Healthcare Realty Trust SEC filings (Ticker: HR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Healthcare Realty Trust's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Healthcare Realty Trust's regulatory disclosures and financial reporting.
Healthcare Realty Trust Inc. (HR) received a Rule 144 notice indicating that Executive VP & COO Robert E. Hull plans to sell 21,000 shares of common stock through J.P. Morgan Securities LLC. The shares have an aggregate market value of $401,520, with the approximate sale date stated as September 8, 2026 on the NYSE.
The shares to be sold arise from vested restricted stock grants received from the issuer for services rendered, including 660 shares vested on December 11, 2023, 19,261 shares vested on December 11, 2024, and 1,079 shares vested on December 31, 2024.
Healthcare Realty Trust Incorporated is registering for resale up to 36,000,000 shares of Class A common stock that may be issued upon exchange of its operating partnership’s $700,000,000 3.00% Exchangeable Senior Notes due 2032. These notes, issued in May 2026 by Healthcare Realty Holdings, L.P. and fully and unconditionally guaranteed by the company, are exchangeable under specified circumstances into common stock or cash, at the company’s sole discretion. Any shares issued upon exchange may be sold from time to time by the noteholders as selling securityholders.
This is a shelf resale registration; the company will not receive proceeds from any share sales, though it will pay related registration expenses. Its common stock trades on the NYSE under “HR,” with a last reported price of $21.53 on July 30, 2026. As of June 30, 2026, 342,719,760 common shares were outstanding, out of 1,000,000,000 authorized common and 200,000,000 authorized preferred shares. As a healthcare-focused UPREIT, the company operates through Healthcare Realty Holdings, L.P., in which it held a 98.8% partnership interest as of June 30, 2026, and it maintains 9.8% stock ownership limits to support REIT qualification.
Healthcare Realty Trust Incorporated and Healthcare Realty Holdings, L.P. filed an automatic shelf registration statement on Form S-3ASR with the SEC on July 31, 2026, together with a prospectus supplement for an existing at-the-market equity program for up to $1,000,000,000 of Class A common stock.
The new registration statement replaced a prior automatic shelf filed on August 8, 2023, which was deemed terminated when the new statement became effective on July 31, 2026. Because no shares had been sold previously under the at-the-market program, the full $1,000,000,000 of common stock capacity remains available for sale under the equity distribution agreements, the new registration statement, and the ATM prospectus supplement. An opinion of Venable LLP regarding the validity of the common stock issuable under this program was filed as an exhibit.
Healthcare Realty Trust Incorporated reported second‑quarter 2026 revenue of $281,849 thousand, down from $297,502 thousand a year earlier, and a net loss of $43,955 thousand versus $160,144 thousand. For the first six months, revenue was $560,839 thousand with a net loss of $43,934 thousand, narrower than $205,532 thousand in 2025.
Performance reflected lower depreciation, interest expense and sharply reduced real estate impairments of $42.8 million year‑to‑date compared with $151.0 million, alongside continued asset sales. Total assets were $9,001,151 thousand and notes and bonds payable rose to $4,166,944 thousand, including new $700 million 3.00% 2032 exchangeable senior notes. Operating cash flow was $195,063 thousand, supporting $175,000 thousand of share repurchases and $0.48 per‑share dividends in the first half, with 342,719,760 shares outstanding as of June 30, 2026.
Healthcare Realty Trust reported second quarter 2026 GAAP net loss of $(0.13) per share, NAREIT FFO of $0.36 per share and Normalized FFO of $0.41 per share. Funds available for distribution were $109.4 million with a 76% payout ratio.
Same store cash NOI grew 5.1%, supported by 1.5 million square feet of lease executions, 88.5% tenant retention and 4.8% cash leasing spreads. Since last quarter the company arranged about $200 million of joint venture acquisitions and $83 million of dispositions and ended June 30 with roughly $1.6 billion of liquidity and Run Rate Net Debt to Adjusted EBITDA of 5.6x.
The company issued $700 million of 3.00% Exchangeable Senior Notes due 2032, largely to refinance $600 million notes due 2026, repurchased 3.8 million shares for $75 million and secured a $400 million delayed draw term loan. The board declared a $0.24 per share dividend and increased 2026 Normalized FFO guidance to $1.62–$1.66 per share and Same Store Cash NOI growth guidance to 4.25%–5.00%.
Healthcare Realty Trust Inc senior vice president and chief accounting officer Amanda L. Callaway reported an open-market sale of common stock. She sold 25,767 shares at a weighted-average price of $20.37 per share, in multiple trades between $20.32 and $20.45, and now holds 109,954 shares directly.
HR reported a Form 144 notice indicating an affiliated holder, Northwestern Mutual Investment Services LLC, has listed Common Stock for proposed sale with a filing date of 06/23/2026. The filing lists multiple equity compensation grants with explicit share counts tied to grant dates.
Healthcare Realty Trust Inc director Thomas N. Bohjalian reported a compensation-related grant of common stock. He received 6,683 shares of common stock on May 19, 2026 at a value of $20.20 per share, classified as a “Grant, award, or other acquisition.”
After this non-derivative acquisition, Bohjalian directly owns 92,203 shares of Healthcare Realty Trust Inc common stock. The filing reflects an increase in his equity stake through an award rather than an open-market purchase or sale.
Healthcare Realty Trust Inc director David Henry reported an equity award of common stock. He received 6,683 shares of common stock on May 19, 2026 at a reference price of $20.20 per share as a grant, award, or other acquisition rather than an open-market purchase.
After this award, Henry directly holds a total of 15,701 shares of Healthcare Realty Trust Inc common stock. The filing does not show any sales or derivative exercises, indicating this was a compensation-related share grant that increased his direct ownership position.